1. Home
  2. NBTB vs SRPT Comparison

NBTB vs SRPT Comparison

Compare NBTB & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBTB

NBT Bancorp Inc.

HOLD

Current Price

$43.79

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$22.20

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTB
SRPT
Founded
1856
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
NBTB
SRPT
Price
$43.79
$22.20
Analyst Decision
Buy
Hold
Analyst Count
3
29
Target Price
$52.33
$26.23
AVG Volume (30 Days)
195.7K
3.6M
Earning Date
01-26-2026
11-03-2025
Dividend Yield
3.38%
N/A
EPS Growth
5.89
N/A
EPS
3.02
N/A
Revenue
$629,728,000.00
$2,413,715,000.00
Revenue This Year
$27.08
$13.83
Revenue Next Year
$9.17
N/A
P/E Ratio
$14.52
N/A
Revenue Growth
16.88
47.15
52 Week Low
$37.31
$10.42
52 Week High
$52.44
$129.84

Technical Indicators

Market Signals
Indicator
NBTB
SRPT
Relative Strength Index (RSI) 67.15 58.69
Support Level $41.38 $21.44
Resistance Level $42.58 $22.85
Average True Range (ATR) 1.06 1.27
MACD 0.21 0.43
Stochastic Oscillator 92.40 89.08

Price Performance

Historical Comparison
NBTB
SRPT

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: